Neogen Corporation (NEOG)
| Market Cap | 2.57B +95.6% |
| Revenue (ttm) | 884.00M -0.3% |
| Net Income | -56.10M |
| EPS | -0.26 |
| Shares Out | 218.31M |
| PE Ratio | n/a |
| Forward PE | 34.59 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 2,408,511 |
| Open | 11.68 |
| Previous Close | 11.68 |
| Day's Range | 11.45 - 11.99 |
| 52-Week Range | 5.37 - 14.26 |
| Beta | 1.86 |
| Analysts | Buy |
| Price Target | 14.00 (+19.05%) |
| Earnings Date | Oct 6, 2026 |
About NEOG
Neogen Corporation develops, manufactures, and markets various products and services for food and animal safety in the United States and internationally. It operates through Food Safety and Animal Safety segments. The company offers diagnostic test kits and complementary products to detect dangerous and/or unintended substances in human food and animal feed, such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns. I... [Read more]
Financial Performance
In fiscal year 2026, Neogen's revenue was $870.40 million, a decrease of -2.72% compared to the previous year's $894.70 million. Losses were -$7.90 million, -99.28% less than in 2025.
Financial StatementsAnalyst Summary
According to 4 analysts, the average rating for NEOG stock is "Buy." The 12-month stock price target is $14.0, which is an increase of 19.05% from the latest price.
News
Neogen® To Participate in 2026 UBS Global Healthcare Conference
LANSING, Mich.--(BUSINESS WIRE)--Neogen® Corporation (NASDAQ: NEOG) announced today that the Company will participate in the 2026 UBS Global Healthcare Conference in Palm Beach Gardens, FL on Tuesday,...
Neogen plans to boost R&D investment by roughly 50% in FY27
Neogen (NEOG) hosted its 2026 Investor Day, “Shaping the Future of Food Safety,” in New York City, where the company’s senior leadership team outlined a comprehensive strategy for sustained profitable...
Neogen Outlines Strategy for Growth, Innovation and Margin Expansion at 2026 Investor Day
LANSING, Mich.--(BUSINESS WIRE)--Neogen Corporation (NASDAQ: NEOG) today hosted its 2026 Investor Day, "Shaping the Future of Food Safety," in New York City, where the company's senior leadership team...
Neogen Transcript: Investor Day 2026
The plan moves from FY26 stabilization to FY27 acceleration and FY28 expansion, targeting high-single-digit to low-double-digit growth, high-50% gross margin, ~30% adjusted EBITDA margin and 80% FCF conversion by FY31. Growth relies on solutions selling, innovation and operating leverage.
Neogen Slides: FY 2026
Neogen has posted slides in relation to its FY 2026 quarterly earnings report, which was published on October 7, 2026.
Neogen Press release: FY 2026
Neogen issued a press release on October 7, 2026, disclosing material business information to investors.
Neogen Earnings Call Transcript: Q1 2027
Q1 FY27 revenue reached $222.8 million, with 8.1% core growth and adjusted EBITDA margin expansion of 170 bps. FY27 revenue and adjusted EBITDA guidance were raised, while Petrifilm transfer and debt reduction remain key priorities.
Neogen Earnings release: Q1 2027
Neogen released its Q1 2027 earnings on October 6, 2026, summarizing the period's financial results.
Neogen Quarterly report: Q1 2027
Neogen has published its Q1 2027 quarterly earnings report on October 6, 2026.
Neogen Slides: Q1 2027
Neogen has posted slides in relation to its Q1 2027 quarterly earnings report, which was published on October 6, 2026.
Neogen reports Q1 adjusted EPS 8c, consensus (7c)
Reports Q1 revenue $222.8M, consensus $208.18M. “As we entered fiscal year 2027, our focus shifted from strengthening fundamentals to scaling them to drive more consistent execution, improved customer...
Neogen raises FY27 revenue view to $885M-$890M from $880M-$885M
Consensus $883.17M. Raises FY27 adjusted EBITDA view to $181M-$183M from $180M-$182M.
Neogen Reports First-Quarter Financial Results for Fiscal Year 2027
LANSING, Mich.--(BUSINESS WIRE)--Neogen® Corporation (NASDAQ: NEOG), an innovative leader in food safety solutions, announced its financial results for the first quarter of fiscal year 2027. “As we en...
Neogen enters collaboration, invests in Hinalea Imaging
Neogen (NEOG) is advancing its innovation strategy by combining deep food safety expertise with emerging technologies to introduce novel solutions to the Food Safety industry that address evolving cus...
Neogen Announces Strategic Collaboration with Hinalea Imaging to Advance Digital Food Safety Solutions
LANSING, Mich.--(BUSINESS WIRE)--Neogen® Corporation (NASDAQ: NEOG), a global leader in food safety solutions, is advancing its innovation strategy by combining deep food safety expertise with emergin...
NEOG Investors Have Opportunity to Join Neogen Corporation Fraud Investigation with SBS Law
LOS ANGELES--(BUSINESS WIRE)---- $NEOG--NEOG Investors Have Opportunity to Join Neogen Corporation Fraud Investigation with SBS Law.
NEOG SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Neogen
NEOG shares gave up as much as 7.22% on FDA action over the recalled HYCOAT equine product. The selloff came with no earnings report on the calendar until October 6.
Neogen Transcript: AGM 2026
The meeting confirmed a quorum and addressed five proposals, all of which passed with strong shareholder support. Directors were elected, executive compensation was approved, auditors were ratified, and incentive and stock purchase plans were amended. No questions were raised during the Q&A.
Neogen price target raised to $14 from $12 at Guggenheim
Guggenheim raised the firm’s price target on Neogen (NEOG) to $14 from $12 and keeps a Buy rating on the shares ahead of the company’s upcoming investor day on October…
Neogen selloff after FDA warning letter ‘overdone,’ says Guggenheim
Guggenheim analyst Subbu Nambi notes that Neogen (NEOG) shares sold off after the FDA issued warning letter related to Neogen Vet HYCOAT for veterinary wound care. However, after speaking with…
Neogen issued FDA warning letter for Neogen Vet HYCOAT
The FDA posted a warning letter, dated September 23, to its site earlier that states in part: “This Warning Letter summarizes significant violations of the Federal Food, Drug, and Cosmetic…
Neogen Proxy statement: Proxy filing
Neogen filed a proxy statement on September 28, 2026, providing details for shareholder voting and corporate governance matters.
Neogen Announces First-Quarter Earnings Release Date
LANSING, Mich.--(BUSINESS WIRE)--Neogen® Corporation (NASDAQ: NEOG) will issue its first-quarter earnings release after the closing of the market on October 6, 2026. Executives from the company will h...
Neogen to Host Investor Day on October 7, 2026
LANSING, Mich.--(BUSINESS WIRE)--Neogen® Corporation (NASDAQ: NEOG) announced today that it will host an Investor Day on Wednesday, October 7, 2026, at 9 a.m. ET in New York City. The focus of the eve...
Neogen upgraded to Overweight from Neutral at Piper Sandler
Piper Sandler upgraded Neogen (NEOG) to Overweight from Neutral with a price target of $14, up from $13. The company has posted several consecutive quarters of improving performance, with food…